1. Home
  2. TPR vs UTHR Comparison

TPR vs UTHR Comparison

Compare TPR & UTHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tapestry Inc.

TPR

Tapestry Inc.

HOLD

Current Price

$131.15

Market Cap

24.1B

ML Signal

HOLD

Logo United Therapeutics Corporation

UTHR

United Therapeutics Corporation

HOLD

Current Price

$505.90

Market Cap

20.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TPR
UTHR
Founded
1941
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Apparel
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
24.1B
20.3B
IPO Year
2000
1999

Fundamental Metrics

Financial Performance
Metric
TPR
UTHR
Price
$131.15
$505.90
Analyst Decision
Buy
Buy
Analyst Count
18
12
Target Price
$121.35
$495.08
AVG Volume (30 Days)
2.8M
464.8K
Earning Date
02-05-2026
10-29-2025
Dividend Yield
1.22%
N/A
EPS Growth
N/A
16.08
EPS
1.25
26.38
Revenue
$7,207,800,000.00
$3,128,400,000.00
Revenue This Year
$6.01
$13.64
Revenue Next Year
$4.55
$5.78
P/E Ratio
$104.97
$19.23
Revenue Growth
8.14
13.50
52 Week Low
$58.39
$266.98
52 Week High
$131.40
$519.99

Technical Indicators

Market Signals
Indicator
TPR
UTHR
Relative Strength Index (RSI) 75.75 61.16
Support Level $121.95 $498.76
Resistance Level $127.54 $519.99
Average True Range (ATR) 3.14 11.19
MACD 0.96 0.18
Stochastic Oscillator 99.59 69.81

Price Performance

Historical Comparison
TPR
UTHR

About TPR Tapestry Inc.

Based in New York City, Tapestry is the parent company of accessories and fashion brand Coach, which accounted for 80% of its revenue and well over 90% of its operating profit in fiscal 2025. Handbags accounted for 58% of the brand's fiscal 2025 revenue. Coach products are sold through more than 900 company-owned stores, e-commerce, and third-party stores in North America, Asia, and Europe. Tapestry also owns Kate Spade (17% of fiscal 2025 revenue), which operates about 170 stores and generated 52% of its sales from handbags in fiscal 2025. Kate Spade is known for its colorful patterns and graphics. Tapestry sold its smallest brand, luxury footwear maker Stuart Weitzman, to Caleres in August 2025.

About UTHR United Therapeutics Corporation

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. In addition, it is developing a pipeline of projects that includes new indications and delivery devices for existing products and new products to treat PAH and other conditions.

Share on Social Networks: